Bart van Hoek

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli et al. · The Lancet Oncology · 2008 · 2K citations · Full text

Medicine, Oncology, Surgery +13

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum et al. · Hepatology · 2013 · 720 citations · Full text

Medicine, Internal Medicine, Oncology +12

Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial

Rianne van Rijn, Ivo J. Schurink, Y. de Vries et al. · New England Journal of Medicine · 2021 · 620 citations · Full text

Medicine, Surgery, Hepatology +15

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane et al. · The Lancet Infectious Diseases · 2016 · 446 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16